Medical Cannabis
| Medical Cannabis | |
|---|---|
 Medical Cannabis ICO Review | |
| Medical Cannabis ICO | |
| Ticker: | MCC |
| ICO start: | 2018-08-31 00:00:00 |
| ICO end: | 2018-09-30 00:00:00 |
| Price: | 1 MCC = 0.1 EUR |
| Tokens: | 2,750,000,000 MCC |
| Distributed: | 50% |
| Minimum: | 15 EUR |
| Accepting: | ETH, BTC, XRP, Fiat |
Be a part of Medical Revolution break-through with Innovation Driven Medical Technology using Cannabis for Treatment of Cancer, Multiple Sclerosis, Epilepsy, HIV/AIDS, Post-Traumatic Stress Disorder and many more chronic diseases.
The Company through its Medical Research Institute has successfully modified & re-engineered the Cannabis plant. The genetically modified plant enhances properties of the Cannabis to be used for medical purpose.
Contents
Description
- The Company offers Revenue Sharing to MCan’s coin Holders on a Monthly Basis.
- The Company offers Dividend to MCan coin Holders on a quarterly basis.
- The Company generously provides 1 free listed share for participants who hold 1000 MCan coins bought during Pre-ICO Period once the Company is listed on NASDAQ or London Stock Exchange.
- Referral commissions of 5% will be distributed via smart contract to holders of Medical Cannabis (MCan) coins.
- Pre-ICO Discount of 30% for MCan coins.
- The Company firmly believes in Capital Appreciation of the MCan coins(ICO).
- The Company strongly feels in the Positive Appreciation of the Listed Share (IPO).
Roadmap
| “ | 2018: Project Conceptualization Started Corporation with various blockchain specialist, advisors to form strategic alliance Form Strategic Alliance with other Medical Cannabis Research and Cultivation companies ICO – Pre-Sale & Institutional Sale Pre- ICO 10% & ICO 50% of the coins will be distributed to expand EIMCR Form strategic alliance with R&D departments in Universities in the area Finalise discussions with Governmental figures 2019: Strategic Alliance with companies to produce MCan Products Establishment of pharmaceutical manufacturing facilities Production of MCan cultivation Begins Adding more and the very best Consultants, Doctors and Scientists. Medical Cannabis harvest All Production of MCan Products Begins 2020: Aggressive expansion to 13 new countries Expansion to new verticals, concrete plans set and teams ready to expand to 13 countries in 2 years. 2021: IPO (Initial Public Offering in major Global Exchanges) NASDAQ, London Stock Exchange (LSE). Further expansion & Global dominance Aggressive marketing in current markets to 8 more new countries in 2 years. Expansion of Manufacturing Facilities in few countries. Blockchain era continues……[1] | ” |
Team
| name: | title: | links: | group: | photo: | iss: |
|---|---|---|---|---|---|
| Chandra Sekar | Chairman |  | 3.2 | ||
| Avtar Chagger | CEO |  | 3.2 | ||
| Yossee Attias | CFO |  | 3.2 | ||
| Marta Mróz | Executive Director – Safety, Hygiene and Environment |  | 3.2 | ||
| Agnieszka Wieczorek | Blockchain Developer |  | 3.2 |
External links
Medical Cannabis on Twitter
Medical Cannabis on Telegram
Medical Cannabis on Facebook
Medical Cannabis on Medium
Medical Cannabis on Bitcointalk
Medical Cannabis on Reddit
Medical Cannabis on Youtube
Medical Cannabis Official Website
Medical Cannabis Whitepaper